Assets Alterar Data
Acadia Pharmaceuticals USD 748.96M 116.42M 2023-12
Agios Pharmaceuticals USD 937.12M 70.14M 2023-12
Akebia Therapeutics USD 241.7M 6.7M 2023-12
Amgen USD 97.15B 6.62B 2023-12
AstraZeneca USD 96.09B 457M 2023-09
Bayer EUR 117.24B 4.43B 2023-09
BioMarin Pharmaceutical USD 6.84B 83.44M 2023-12
Bluebird Bio USD 613.61M 49.78M 2023-09
Bristol-Myers Squibb USD 91.26B 2.23B 2023-09
Cytokinetics USD 824.32M 83.7M 2023-12
Eisai JPY 1.33T 28.9B 2023-09
Eli Lilly USD 57.92B 3.1B 2023-09
Esperion Therapeutics USD 221.3M 13.32M 2023-09
Exelixis USD 2.98B 165.56M 2023-09
Genmab DKK 35.24B 3.26B 2023-09
Incyte USD 6.78B 393.87M 2023-12
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
Merck USD 106.73B 2.26B 2023-09
Moderna USD 18.43B 1.02B 2023-12
Nektar Therapeutics USD 442.24M 52.04M 2023-09
Neurocrine Biosciences USD 2.85B 235.1M 2023-09
Pfizer USD 215.02B 5.15B 2023-09
Takeda JPY 14.87T 79.15B 2023-09
Ultragenyx Pharmaceutical USD 1.49B 252.87M 2023-12
Xencor USD 952.69M 174.26M 2023-12



Exelixis Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.